tirzepatide alzheimer's research Preventative semaglutide and treatment does not alter disease progression in the 5xFAD mouse model of disease | Christoffer Clemmensen GLP-1s May Stave Off Dementia,

327 :H989-h1003 93

While blood clots are not a recognized side effect of GLP-1 medications, patients should remain aware of warning signs, particularly given that obesity itself increases thrombotic risk

The recommended starting dose is usually 0.25 mg once a week for the first month, which can be gradually increased to 0.5 mg once a week after the initial four weeks if well tolerated

Minamata disease: an unusual neurological disorder caused by contaminated fish

Accumulated evidence, indicate how bile acids are important modulators of the whole body metabolism, bridging the microbiome to the brain, likely being key signaling molecules in the pathogenesis of obesity and type 2 diabetes